CAMITOTIC

This brand name is authorized in Estonia, Lithuania

Active ingredients

The drug CAMITOTIC contains one active pharmaceutical ingredient (API):

1 Docetaxel
UNII 15H5577CQD - DOCETAXEL

Docetaxel is an antineoplastic agent which acts by promoting the assembly of tubulin into stable microtubules and inhibits their disassembly which leads to a marked decrease of free tubulin.

Read about Docetaxel

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01CD02 Docetaxel L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01C Plant alkaloids and other natural products → L01CD Taxanes
Discover more medicines within L01CD02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: EE Ravimiamet Identifier(s): 1418756, 1418767, 1418778, 1739976
Country: LT Valstybinฤ— vaistลณ kontrolฤ—s tarnyba Identifier(s): 1037853, 1037854, 1037855, 1081940

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈